journal article·2026-02Open access

Epstein‐Barr Virus Expressed Long Non‐Coding RNA ( lncBART s) Regulate EBV Latent Genome Replication

Jiayan Liu, Dittman Lai‐Shun Chung, Larry Ka‐Yue Chow, Shuo Han, Wenkai Yi, Conor J. Cremin, Yingyin Liao, Pui Wang, Bobo Wing‐Yee Mok, Mingfang Ji, Jian Yan, Wei Dai, Honglin Chen

Advanced Science· Volume 13· Issue 8

Abstract

Abstract Epstein‐Barr virus (EBV) is a ubiquitous human virus that is also linked to various human cancers. In EBV‐associated nasopharyngeal carcinoma and gastric carcinoma cells, EBV expresses only essential viral antigens but high levels of long non‐coding RNAs known as BamHI‐A rightward transcripts ( lncBART s). The exact roles lncBART s in the EBV life cycle and the development of EBV‐associated cancers are largely not understood. This study demonstrates that lncBART s play a role in maintaining viral genome replication by affecting the tethering of EBV ori P region to chromosome. Mechanistically, lncBART s interact functionally with a complex consisting of Bromodomain‐containing protein 4 (BRD4), CCTC‐binding factor (CTCF), and EBV nuclear antigen 1 (EBNA1), anchoring their binding at ori P to facilitate EBV episome replication. Additionally, the lncBART s‐BRD4/CTCF complex contributes to the regulation of MYC and BCL2 expression. These findings suggest that lncBART s modulate EBV latency through interactions with ori P region, while lncBART s‐BRD4/CTCF complexes promote host epigenome reprogramming and drive tumorigenesis in EBV‐associated epithelial tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Viral-associated cancers and disorders · Cancer-related molecular mechanisms research · Head and Neck Cancer Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory for Emerging Infectious Diseases and Department of Microbiology The University of Hong Kong Pokfulam Hong Kong SAR China

Centre for Virology Vaccinology and Therapeutics Limited Hong Kong SAR China

Department of Clinical Oncology The University of Hong Kong Pokfulam Hong Kong SAR China

School of Biomedical Sciences Li Ka Shing Faculty of Medicine The University of Hong Kong, Pokfulam Hong Kong SAR China

Department of Biomedical Sciences City University of Hong Kong Hong Kong SAR China

Cancer Research Institute of Zhongshan City Zhongshan People's Hospital Zhongshan Guangdong China

References (62)

Show source-provided references
1. 10.1016/S0140-6736(64)91524-710.1016/S0140-6736(64)91524-7 ↗
2. 10.1038/bjc.1996.41210.1038/bjc.1996.412 ↗
3. 10.1006/scbi.1996.002410.1006/scbi.1996.0024 ↗
4. 10.1038/nrc.2016.9210.1038/nrc.2016.92 ↗
5. 10.1098/rstb.2016.027010.1098/rstb.2016.0270 ↗
6. 10.1038/2281056a010.1038/2281056a0 ↗
7. Shibata D. · Am J Pathol · 1991 · 139 · 469
8. Dunn L. E. M. · J. Virol. · 2023 · 97
9. Silva J. d. M. · Front. Immunol. · 2024 · 15
10. 10.1002/j.1460-2075.1989.tb08404.x10.1002/j.1460-2075.1989.tb08404.x ↗
11. 10.1128/JVI.74.7.3082-3092.200010.1128/JVI.74.7.3082-3092.2000 ↗
12. 10.1073/pnas.181172811510.1073/pnas.1811728115 ↗
13. 10.3389/fonc.2019.0112010.3389/fonc.2019.01120 ↗
14. 10.1128/JVI.72.8.6614-6620.199810.1128/JVI.72.8.6614-6620.1998 ↗
15. 10.1128/jvi.67.6.3217-3225.199310.1128/jvi.67.6.3217-3225.1993 ↗
16. 10.1099/vir.0.006551-010.1099/vir.0.006551-0 ↗
17. 10.1128/JVI.01492-1510.1128/JVI.01492-15 ↗
18. 10.3389/fonc.2019.0112010.3389/fonc.2019.01120 ↗
19. 10.4143/crt.2011.43.4.25010.4143/crt.2011.43.4.250 ↗
20. 10.1016/j.canlet.2022.21564610.1016/j.canlet.2022.215646 ↗
21. 10.1371/journal.ppat.100534410.1371/journal.ppat.1005344 ↗
22. 10.1128/JVI.00613-1610.1128/JVI.00613-16 ↗
23. 10.1038/nature0710310.1038/nature07103 ↗
24. 10.3390/v611421210.3390/v6114212 ↗
25. 10.1038/242044a010.1038/242044a0 ↗
26. 10.1073/pnas.72.4.147710.1073/pnas.72.4.1477 ↗
27. 10.1016/j.tim.2019.09.00210.1016/j.tim.2019.09.002 ↗
28. 10.1016/S0092-8674(04)00402-710.1016/S0092-8674(04)00402-7 ↗
29. 10.1128/JVI.00502-0610.1128/JVI.00502-06 ↗
30. 10.1128/JVI.78.22.12308-12319.200410.1128/JVI.78.22.12308-12319.2004 ↗
31. 10.1099/vir.0.007344-010.1099/vir.0.007344-0 ↗
32. 10.1016/0042-6822(92)90181-N10.1016/0042-6822(92)90181-N ↗
33. 10.1182/blood.V93.9.3026.409k28_3026_303210.1182/blood.V93.9.3026.409k28_3026_3032 ↗
34. 10.1128/JVI.79.3.1724-1733.200510.1128/JVI.79.3.1724-1733.2005 ↗
35. 10.1016/j.plasmid.2007.01.00310.1016/j.plasmid.2007.01.003 ↗
36. 10.1038/s41598-017-02456-y10.1038/s41598-017-02456-y ↗
37. 10.1038/s41592-020-0866-010.1038/s41592-020-0866-0 ↗
38. 10.1016/S0014-5793(01)03309-910.1016/S0014-5793(01)03309-9 ↗
39. 10.1016/j.cell.2011.08.01710.1016/j.cell.2011.08.017 ↗
40. Jung J. U. · PLoS Pathog. · 2011 · 7
41. 10.1371/journal.ppat.100465610.1371/journal.ppat.1004656 ↗
42. 10.1093/nar/gkad93610.1093/nar/gkad936 ↗
43. 10.1006/scbi.2001.040910.1006/scbi.2001.0409 ↗
44. 10.1016/j.chom.2017.09.00110.1016/j.chom.2017.09.001 ↗
45. 10.1016/j.cell.2015.01.01510.1016/j.cell.2015.01.015 ↗
46. 10.1016/j.semcancer.2014.02.00210.1016/j.semcancer.2014.02.002 ↗
47. 10.1128/.20.17.6537-6549.200010.1128/.20.17.6537-6549.2000 ↗
48. 10.1038/2097410.1038/20974 ↗
49. 10.1016/j.semcancer.2014.01.00310.1016/j.semcancer.2014.01.003 ↗
50. 10.1371/journal.ppat.100302110.1371/journal.ppat.1003021 ↗
51. 10.1016/j.molcel.2023.11.02210.1016/j.molcel.2023.11.022 ↗
52. 10.1101/cshperspect.a01302910.1101/cshperspect.a013029 ↗
53. 10.1016/S0092-8674(01)00458-510.1016/S0092-8674(01)00458-5 ↗
54. 10.1073/pnas.18134799810.1073/pnas.181347998 ↗
55. 10.1016/j.ebiom.2022.10435710.1016/j.ebiom.2022.104357 ↗
56. 10.1038/s41467-023-37347-610.1038/s41467-023-37347-6 ↗
57. Hutt‐Fletcher L. M. · J. Virol. · 2017 · 91
58. 10.1016/j.celrep.2014.07.03710.1016/j.celrep.2014.07.037 ↗
59. Wang L. W. · J. Virol. · 2017 · 91
60. Lin W. · Nat. Commun. · 2018 · 9
61. 10.1093/nar/gkz04910.1093/nar/gkz049 ↗
62. 10.1038/nmeth.268810.1038/nmeth.2688 ↗